Latest Peplin news

news

09-June-09

Peplin Initiates Phase 3 Clinical Trials with PEP005 Gel in AK on Face and Scalp read more

28-May-09

Peplin's Positive Phase II AK Trial Results Published in JAAD read more

17-May-09

Positive Results for Peplin's First Phase III AK Trial read more

15-May-09

Peplin Results for the Quarter Ended 31 March 2009 read more

›› More News

Eugene Bauer MD

President, Chief Medical Officer and Executive Director

Eugene Bauer, M.D. has served as a member of our board of directors since June 2006 and as President and Chief Medical Officer since August 18, 2008.

From November 2004 to June 2008, Dr. Bauer served as the Chief Executive Officer of Neosil, Inc., a dermatology company. Dr. Bauer is a Lucy Becker Professor, Emeritus, in the School of Medicine at Stanford University, a position he has held since 2002. He served as Vice President for Medical Affairs and Dean of the Stanford University School of Medicine from 1995 to 2001 and served as Chair of the Department of Dermatology at the Stanford University School of Medicine from 1988 to 1995. Dr. Bauer is also a co-founder and emeritus member of the board of directors of Connetics Corporation, a specialty pharmaceutical company acquired by Stiefel Laboratories in 2006.

In addition, Dr. Bauer is a member of the board of directors of Protalex, Inc., a publicly held biotechnology company, Echo Healthcare Acquisition Corp., a publicly held acquisition vehicle of businesses in the healthcare industry, and Modigene, Inc., a publicly held biopharmaceutical company.

Dr. Bauer received a B.S.Med. and a M.D. from Northwestern University.

Board of Directors

Executive Management